DNTTIP1 Knockout Jurkat Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Jurkat T-lymphocyte cell line, engineered to disrupt the DNTTIP1 gene. This loss-of-function model provides a tool for investigating the roles of terminal deoxynucleotidyltransferase-interacting protein 1 (DNTTIP1) in V(D)J recombination and transcriptional regulation. The polyclonal nature of the knockout population avoids clonal selection artifacts, offering a more heterogeneous representation of gene disruption effects suitable for functional genomic studies.
Jurkat cells are an immortalized T-lymphocyte line originally established from a patient with acute T-cell leukemia, widely employed as a model system for T-cell activation, signaling, and apoptosis. These cells exhibit rapid proliferation and retain key characteristics of T-cell progenitors, including responsiveness to T-cell receptor (TCR) stimulation and expression of downstream signaling components. Their leukemic origin and well-defined signal transduction pathways make Jurkat cells particularly suitable for dissecting mechanisms of V(D)J recombination, chromatin remodeling, and oncogenic transformation in T-cell malignancies.
DNTTIP1 encodes a ubiquitously expressed nuclear protein that directly interacts with terminal deoxynucleotidyltransferase (TdT), augmenting its nucleotide addition activity during V(D)J recombination to promote junctional diversity at immunoglobulin and T-cell receptor gene loci. Additionally, DNTTIP1 associates with histone deacetylases HDAC1 and HDAC2, histone H3, and nucleolin, implicating it in chromatin remodeling and transcriptional repression. Functioning downstream of T-cell receptor activation and NOTCH1 signaling, DNTTIP1 modulates TdT-mediated catalysis and influences histone acetylation status, thereby coordinating antigen receptor diversity with broader gene expression programs. This dual role is reflected in its interacting partners and pathway components, including RAG1, RAG2, and HDAC1.
In the Jurkat cell context, disruption of DNTTIP1 provides a physiologically relevant platform to examine how V(D)J recombination fidelity and T-cell receptor repertoire diversity are controlled, shedding light on mechanisms underlying immunodeficiency syndromes and T-cell acute lymphoblastic leukemia (T-ALL). The knockout model facilitates assessment of altered TdT activity, changes in histone acetylation patterns, and dysregulated gene repression downstream of oncogenic or developmental signals. By enabling the study of DNTTIP1-dependent effects on cell proliferation, apoptosis, and signaling within a T-cell lineage environment, this reagent supports investigations into both normal lymphocyte development and leukemogenic processes.
Typical applications include Western blotting and RT-qPCR for expression verification, RNA-seq for transcriptomic profiling of V(D)J recombination and transcriptional changes, flow cytometry for phenotypic analysis, and cell proliferation or apoptosis assays to evaluate functional outcomes. TdT activity assays directly measure effects on nucleotide addition, while co-immunoprecipitation and ChIP-qPCR allow interrogation of DNTTIP1 interactions with TdT, HDAC1, and chromatin. Reporter assays can be employed to assess transcriptional regulation by DNTTIP1 complexes. This polyclonal knockout population is a versatile resource for advancing research in adaptive immunity, gene regulation, and T-cell malignancies. For more information, please contact Ascent Research.
